Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
MA01 - Improvement and Implementation of Lung Cancer Screening
- Type: Mini Oral Session
- Track: Radiology/Staging/Screening
- Presentations: 12
- Moderators:M. Studnicka
- Coordinates: 12/05/2016, 11:00 - 12:30, Lehar 1-2
-
+
MA01.06 - Long-Term Follow-Up of Small Pulmonary Ground-Glass Nodules Stable for 3 Years: Proper Follow-Up Period and Risk Factors for Subsequent Growth
11:30 - 11:36 | Author(s): J. Cho
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Epidemiology/Tobacco Control and Cessation/Prevention
- Presentations: 59
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.01-032 - Emergency Department Visits by Lung Cancer Patients in Korea
14:30 - 14:30 | Author(s): D.W. Park
- Abstract
Loading...
-
+
P1.06 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 47
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.06-024 - Distinctive Patterns of Primary Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): D.S. Lee
- Abstract
Loading...
-
+
P1.07 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 55
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.07-014 - Impact of Chemotherapy for Small Cell Lung Cancer in the Third Line and beyond, a SEER-MEDICARE Analysis
14:30 - 14:30 | Author(s): S. Kim
- Abstract
Loading...
-
+
MA05 - Innovative Techniques in Pulmonology and the Impact on Lung Cancer
- Type: Mini Oral Session
- Track: Pulmonology
- Presentations: 12
- Moderators:J. Eckmayr
- Coordinates: 12/05/2016, 16:00 - 17:30, Strauss 1
-
+
MA05.05 - Genomic Profiles of Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
16:30 - 16:36 | Author(s): J.A. Hwang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA08 - Targeted Therapies in Brain Metastases
- Type: Oral Session
- Track: Advanced NSCLC
- Presentations: 8
- Moderators:D. Ball
- Coordinates: 12/05/2016, 16:00 - 17:30, Schubert 1
-
+
OA08.06 - Brigatinib Activity in Patients with ALK+ NSCLC and Intracranial CNS Metastases in Two Clinical Trials
16:55 - 17:05 | Author(s): S.N. Gettinger
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Treatment Monitoring in Advanced NSCLC
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Presentations: 12
- Moderators:R. Perez-Soler
- Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 3-4
-
+
MA08.03 - Osimertinib vs Platinum-Pemetrexed for T790M-Mutation Positive Advanced NSCLC (AURA3): Plasma ctDNA Analysis
11:12 - 11:18 | Author(s): Y.-. Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA12 - SBRT and Other Issues in Early Stage NSCLC
- Type: Oral Session
- Track: Early Stage NSCLC
- Presentations: 8
- Moderators:D. De Ruysscher
- Coordinates: 12/06/2016, 11:00 - 12:30, Strauss 2
-
+
OA12.07 - Selection for Adjuvant Chemotherapy in Stage IB Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis
12:05 - 12:15 | Author(s): J.H. Jeon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.03a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 72
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03a-037 - Prognosis of Advanced Non-Small Cell Lung Cancer (NSCLC) Refractory to First-Line Platinum Chemotherapy
14:30 - 14:30 | Author(s): H.K. Ahn
- Abstract
Loading... -
+
P2.03a-038 - Phase III Trial of Pemetrexed/Carboplatin vs Pemetrexed Only in Chemo-Naïve Elderly Non-SQCC NSCLC Patients Aged ≥ 70
14:30 - 14:30 | Author(s): D.H. Lee
- Abstract
Loading... -
+
P2.03a-061 - Randomized Phase II Trial Comparing Intercalation of Afatinib to Pemetrexed with Pemetrexed Alone after Failure of Platinum Doublet Therapy
14:30 - 14:30 | Author(s): S. Yoon
- Abstract
Loading...
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-038 - The Diagnostic and Prognostic Value of CSF Cyfra 21-1 in Patients with Leptomeningeal Metastasis of Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Hyun
- Abstract
Loading... -
+
P2.03b-053 - Role of KRAS Mutation Status in NSCLC Patients Treated on SWOG S0819, a Phase III Trial of Chemotherapy with or without Cetuximab
14:30 - 14:30 | Author(s): P. Mack
- Abstract
Loading...
